Spatial and temporal sequence of capsule construction in Cryptococcus neoformans

被引:68
作者
Pierini, LM
Doering, TL
机构
[1] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA
[2] Cornell Univ, Dept Biochem, Weill Med Coll, New York, NY 10021 USA
关键词
D O I
10.1046/j.1365-2958.2001.02504.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The pathogenic yeast Cryptococcus neoformans is distinguished by an extensive polysaccharide capsule, which impedes host defences and is absolutely required for fungal virulence. Despite the biological importance of the capsule, nothing is known about how it is assembled. Substantial capsule growth occurs in two distinct situations relevant to cryptococcal pathogenesis: formation of new buds and Induction of capsule on mature cells. We developed pulse-chase protocols to examine these events in a dynamic way using a variety of microscopy techniques. We show that the capsule overlying buds is newly synthesized and differs physically from the corresponding parental material. New capsule formed by mature cells upon induction of synthesis is added at the inner aspect of the existing structure, displacing pre-existing material outwards. Surprisingly, new polysaccharide material is also deposited throughout the capsule, yielding a progressively denser structure. These results yield the first model of capsule synthesis and open new lines of investigation into the underlying mechanisms.
引用
收藏
页码:105 / 115
页数:11
相关论文
共 47 条
[1]   Signal transduction pathways regulating differentiation and pathogenicity of Cryptococcus neoformans [J].
Alspaugh, JA ;
Perfect, JR ;
Heitman, J .
FUNGAL GENETICS AND BIOLOGY, 1998, 25 (01) :1-14
[2]  
Bozzola J.J., 1992, ELECTRON MICROS, DOI DOI 10.1086/417649
[3]   What makes Cryptococcus neoformans a pathogen? [J].
Buchanan, KL ;
Murphy, JW .
EMERGING INFECTIOUS DISEASES, 1998, 4 (01) :71-83
[4]   Characterization of a murine monoclonal antibody to Cryptococcus neoformans polysaccharide that is a candidate for human therapeutic studies [J].
Casadevall, A ;
Cleare, W ;
Feldmesser, M ;
Glatman-Freedman, A ;
Goldman, DL ;
Kozel, TR ;
Lendvai, N ;
Mukherjee, J ;
Pirofski, LA ;
Rivera, J ;
Rosas, AL ;
Scharff, MD ;
Valadon, P ;
Westin, K ;
Zhong, ZJ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (06) :1437-1446
[5]  
Casadevall A, 1998, CRYPTOCOCCUS NEOFORM, DOI DOI 10.1128/9781555818241
[6]   WALL STRUCTURE AND BUD FORMATION IN CRYPTOCOCCUS-NEOFORMANS [J].
CASSONE, A ;
SIMONETTI, N ;
STRIPPOLI, V .
ARCHIVES OF MICROBIOLOGY, 1974, 95 (03) :205-212
[7]   Isolation, characterization, and localization of a capsule-associated gene, CAP10, of Cryptococcus neoformans [J].
Chang, YC ;
Kwon-Chung, KJ .
JOURNAL OF BACTERIOLOGY, 1999, 181 (18) :5636-5643
[8]   The second capsule gene of Cryptococcus neoformans, CAP64, is essential for virulence [J].
Chang, YC ;
Penoyer, LA ;
KwonChung, KJ .
INFECTION AND IMMUNITY, 1996, 64 (06) :1977-1983
[9]   COMPLEMENTATION OF A CAPSULE-DEFICIENT MUTATION OF CRYPTOCOCCUS-NEOFORMANS RESTORES ITS VIRULENCE [J].
CHANG, YC ;
KWONCHUNG, KJ .
MOLECULAR AND CELLULAR BIOLOGY, 1994, 14 (07) :4912-4919
[10]   Isolation of the third capsule-associated gene, CAP60, required for virulence in Cryptococcus neoformans [J].
Chang, YC ;
Kwon-Chung, KJ .
INFECTION AND IMMUNITY, 1998, 66 (05) :2230-2236